Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivisimo was a specialized enterprise search and information optimization software company that became a key player in healthcare informatics and life sciences data management. Founded in 2000 as a spin-off from Carnegie Mellon University, the company developed the Velocity platform, which utilized advanced document-clustering algorithms to organize search results into intuitive categories. The company's technology was notably selected by the National Library of Medicine (NLM) to power the search functionality for MedlinePlus and the NLM website, facilitating public and professional access to vast biomedical databases. Vivisimo also served major pharmaceutical companies and government agencies, helping them navigate and analyze complex structured and unstructured data. In 2012, the company was acquired by IBM to bolster its big data analytics portfolio and support the development of the IBM Watson platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivisimo.